lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate
Labeler: alvogen inc.Drug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate
Labeler
alvogen inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
lisdexamfetamine dimesylate 10 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
47781-562
Product ID
47781-562_567bb281-4098-07f8-9503-92299dc1c4c6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214547
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2023-08-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
47781562
Hyphenated Format
47781-562
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate (source: ndc)
Application Number
ANDA214547 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (47781-562-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "567bb281-4098-07f8-9503-92299dc1c4c6", "openfda": {"upc": ["0347781568016", "0347781564018", "0347781567019", "0347781562014", "0347781563011", "0347781565015", "0347781566012"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["7f2dd6ee-3363-c87c-9693-ed838942556c"], "manufacturer_name": ["Alvogen Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (47781-562-01)", "package_ndc": "47781-562-01", "marketing_start_date": "20230825"}], "brand_name": "lisdexamfetamine dimesylate", "product_id": "47781-562_567bb281-4098-07f8-9503-92299dc1c4c6", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "47781-562", "dea_schedule": "CII", "generic_name": "lisdexamfetamine dimesylate", "labeler_name": "Alvogen Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lisdexamfetamine dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "10 mg/1"}], "application_number": "ANDA214547", "marketing_category": "ANDA", "marketing_start_date": "20230825", "listing_expiration_date": "20261231"}